{
    "Trade/Device Name(s)": [
        "Contour NEXT USB Blood Glucose Monitoring System",
        "Contour NEXT USB Blood Glucose Meter",
        "Contour NEXT Blood Glucose Test Strips",
        "Contour NEXT Control Solution",
        "Glucofacts Deluxe Diabetes Management Software"
    ],
    "Submitter Information": "Bayer HealthCare Diabetes Care",
    "510(k) Number": "K121087",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110894"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX",
        "JQP"
    ],
    "Summary Letter Date": "May 30, 2012",
    "Summary Letter Received Date": "June 1, 2012",
    "Submission Date": "June 26, 2012",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Capillary blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Contour NEXT USB Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection",
        "Glucose dehydrogenase enzymatic reaction"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Contour NEXT USB Blood Glucose Monitoring System and associated diabetes management software for home blood glucose measurement.",
    "Indications for Use Summary": "Over-the-counter quantitative measurement of glucose in whole blood from fingertip and palm for single-patient home use; monitoring diabetes control program; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}